Advances in immunohistochemistry technologies are supporting the CD68 Market. Improvements in staining protocols, antibody specificity, tissue preparation, and image analysis are helping laboratories achieve more consistent cellular identification. The CD68 Market was valued at US$ 804.62 million in 2025 and is expected to reach US$ 1,563.69 million by 2034, registering a CAGR of 7.66% during...